Why does chronic stress lead to increased risk for dementia? The answer may lie in the elevation of stress steroids that is seen in the brain during stress, Sara K. Bengtsson suggests in the thesis she is defending at Umeå University in Sweden on March 22.
These stress steroids can inhibit the general brain activity. Allopregnanolon is one of them, and the doctoral thesis shows that chronically elevated levels of allopregnanolone accelerated the disease development in two transgenic Alzheimer disease models. The Alzheimer mice responded with impaired learning and memory. They had also increased brain levels of beta-amyloids, i.e. the proteins that form plaques in Alzheimer's disease.
The thesis also demonstrates that high levels of beta-amyloids corresponded to dysfunction among brain synapses. This was seen after a period of chronically elevated levels of allopregnanolon, but not after placebo treatment. The effects were identified early in the disease development when the animals normally have intact memory function. A similar acceleration of AD in humans could mean the difference between living self-sufficiently at home and living with requirements of professional care.
Sara K. Bengtsson was born in Malmö, Sweden, and completed her pre-university graduation in Ystad. Professionally, Sara K. Bengtsson has worked in various fields and in 2008 she completed her Master's degree in medicine with a major in biomedicine at Umeå University, Sweden, where she now is a postgraduate student at the Department of Clinical Sciences, division of Obstetrics and Gynecology.
On Friday, March 22nd, Sara K. Bengtsson, Department of Clinical Sciences, Umeå University, is publicly defending her thesis with the title "Stress steroids as accelerators of Alzheimer's disease." Effects of chronically elevated levels of allopregnanolone in transgenic AD models.
More information: Read the thesis or abstract at: urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-66572